A leading public health organization aimed to develop an AI-powered detection device capable of identifying viruses and bacteria in real time.

While the concept was groundbreaking, the project faced critical uncertainties: market demand validation, technical feasibility, cost modeling, and long-term commercial viability.

The organization needed a trusted innovation partner to conduct a comprehensive feasibility study that would assess business, technical, and financial aspects, helping determine whether to move forward with the investment.

Vantiqa led a strategic feasibility and innovation validation program, combining data-driven market research, financial modeling, and technology evaluation to ensure a viable path forward.

Our experts:

• Conducted an external environment assessment, including market, industry, and competitive analyses.
• Performed technical feasibility evaluations, assessing potential AI models, data processing requirements, and integration readiness.
• Designed a business feasibility framework to evaluate demand, scalability, and alignment with emerging health technology trends.
• Built a financial model and investment appraisal, analyzing cost–benefit ratios, funding scenarios, and ROI projections.
• Developed a strategic roadmap and business case, outlining multiple go-to-market pathways with associated risk and impact analysis.

The engagement provided the client with a clear, evidence-based strategy for decision-making:

• A validated business case outlining strategic options for device development and commercialization.
• Technical readiness assessment identifying required R&D capabilities and partnerships.
• Comprehensive financial feasibility study detailing investment requirements and projected returns.
• A roadmap for innovation execution, including milestones for prototype development, testing, and market launch.
• Informed executive decisions based on quantifiable data, ensuring risk-aware investment in high-impact innovation.